Akari Therapeutics Plc · NASDAQ:AKTX
Patel Sandip I received 16,413 Akari Therapeutics Plc shares as an award (Form 4)
Traded Aug 18 to Oct 14, 2026 · Filed Oct 16, 2026
From Aug 18 to Oct 14, 2026, Patel Sandip I (Director) received 16,413 Akari Therapeutics Plc shares as an award at US$7.90 for US$130K, leaving 38,877 shares. Filed Oct 16, 2026 (Form 4).
- Awarded
- 16,413 shares
- Price
- US$7.90
- Value
- US$130K
- Holding after
- 38,877 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | American Depositary Shares representing Ordinary Shares | Award | 12,100 | US$7.90 | 24,512 | Direct |
| Oct 5, 2026 | American Depositary Shares representing Ordinary Shares | Award | 4,313 | US$7.90 | 28,825 | Direct |
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 3,866 | US$0.00 | 32,691 | Direct |
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 6,186 | US$0.00 | 38,877 | Direct |
Source
Download original · View original at SEC